VARENICLINE TARTRATE | A214255 | MANKIND PHARMA LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
Par Pharmaceutical, Inc. et al v. Alkem Laboratories Ltd. ANDA 214255Varenicline Tartrate | E.D. Tex. | 2023-09-01 | Terminated 2024-12-10 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$0.4919
per ea
Lowest NADAC/Unit
$0.3191
per ea
Brand NDCs
0
Generic NDCs
4
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68462089504VARENICLINE STARTING MONTH BOX | $0.4919 | EA | Generic | — | 2026-06-17 |
| 68462089404VARENICLINE 1 MG CONT MONTH BX | $0.4185 | EA | Generic | — | 2026-06-17 |
| 68462089456VARENICLINE 1 MG TABLET | $0.4185 | EA | Generic | — | 2026-06-17 |
| 68462089356VARENICLINE 0.5 MG TABLET | $0.3191 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.